Browse current and past press releases from The Michael J. Fox Foundation.
December 23, 2013
Potential Neuroprotective Therapy Ready for Next Stage of Development after Michael J. Fox Foundation Funding
New findings published in JAMA Neurology from research into a potentially protective therapy for Parkinson's disease (PD) show that with medical supervision, urate levels may safely be raised while mitigating risk of complications such as gout. Previous research showed that higher levels of the antioxidant urate were associated with lower risk and slower progression of PD.
In the Phase...Read More
The Michael J. Fox Foundation Expands Fox Trial Finder to Help Accelerate Parkinson's Trials Worldwide
November 13, 2013
Online tool now a global resource to clinical teams and trial volunteers
NEW YORK, NY - Today, The Michael J. Fox Foundation for Parkinson's Research (MJFF) launches its clinical research matching tool Fox Trial Finder (www.foxtrialfinder.org) globally. Previously limited to five English-speaking countries, Fox Trial Finder is now accessible to both trial volunteers and clinical teams across the globe, increasing both the number of Parkinson's clinical trials in the database as well as the numb...Read More
November 12, 2013
The Michael J. Fox Foundation for Parkinson's Research (MJFF), Thomas Jefferson University (Jefferson) and Taconic have collaborated to create, validate and distribute a valuable pre-clinical research tool: a genetically engineered rat with fluorescent dopamine-producing neurons—neurons that are affected in Parkinson's disease.
This unique nonprofit, academic and industry partnership provides easy and open access to this genetically engineered rat model, making it available to all interested re...Read More
The Great Need for Early Diagnostic Tools in the Pursuit of Disease Cures: A Statement from The Michael J. Fox Foundation for Parkinson's Research
November 07, 2013
In the field of neurodegeneration, we are closing in on the mechanisms of diseases such as Parkinson's and Alzheimer's, but one big thing is keeping cures at arm's length. We need biomarkers to definitively diagnose and track disease, stratify clinical research volunteers and test disease-modifying therapies. And we need tools to identify, validate and screen for biomarkers.
Decisions by pharmaceutical companies and the Centers for Medicare & Medicaid Services (CMS) to cover or reimburse for su...Read More
The Michael J. Fox Foundation Leads Charge to Develop Alpha-Synuclein PET Tracer to Image Parkinson's Disease Biomarker
November 07, 2013
The pursuit of an imaging tool to visualize the protein alpha-synuclein, the hallmark pathology of Parkinson's disease (PD), in the brain is the subject of a paper published today in the Journal of Parkinson's Disease by three researchers from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The Foundation has assembled and leads a consortium to develop a radioactive PET tracer that could lead to better therapies and quality of life for Parkinson's patients.
"The time frame for de...Read More
October 16, 2013
Event Aims to Educate on Local Opportunities to Join the Pursuit for a Cure
NEW YORK, NY - The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host a Clinical Trials Fair in New York City on Saturday, October 19, to raise awareness and understanding of local Parkinson's research opportunities among patients, their families and friends, and other interested volunteers.
"I am grateful to the researchers, neurologists and everyone in the Parkinson's community for their contributio...Read More
The New York Stem Cell Foundation Research Institute Announces Partnership with Parkinson's Progression Markers Initiative
October 16, 2013
The New York Stem Cell Foundation (NYSCF) Research Institute has entered into a partnership with the Parkinson's Progression Markers Initiative (PPMI) to build resources for studying Parkinson's disease to accelerate new treatments. Sponsored by The Michael J. Fox Foundation for Parkinson's Research, PPMI is a landmark effort to identify and validate biomarkers of Parkinson's disease. The study is currently under way at 32 clinical sites worldwide with funding from 13 industry partners.
NYSCF w...Read More
The Michael J. Fox Foundation Launches think/able: Miles for a Cure, a Month-long Challenge to Raise $50,000 for Parkinson's Research
October 04, 2013
"Miles for a Cure offers a great way for our community to take action and help raise $50,000 in 30 days," sa...Read More
As Michael J. Fox Returns to Primetime, His Research Foundation Urgently Pursues the Cure for Parkinson's
September 26, 2013
Tonight, Michael J. Fox returns to television as the star of his own sitcom after more than two decades living with Parkinson's disease. Fox's decision to return to primetime has injected Parkinson's into the national conversation -- a conversation already transformed by The Michael J. Fox Foundation for Parkinson's Research (MJFF), which the actor launched in 2000 with the exclusive goal of funding research to speed a cure for the disease.
"What I had in mind was an organization build for spee...Read More
September 25, 2013
Michael J. Fox's return to network television opens door to conversation about brain health
A new online survey of more than 2,000 U.S. adults, sponsored by The Michael J. Fox Foundation for Parkinson's Research (MJFF), reveals that nearly one in five Americans (17 percent) care enough about their brain health that they think about it on a day-to-day basis- but also that myths and misperceptions abound, including a considerable underestimation of the incidence of brain ailments.
Three out of f...Read More
September 13, 2013
To propel biomedical research toward a cure for Parkinson's disease by arming scientists with high-performing laboratory tools, The Michael J. Fox Foundation for Parkinson's Research (MJFF) has launched the Parkinson's Disease Research Tools Consortium. MJFF and seven industry partners have organized to grow the Foundation's ongoing efforts to better understand existing tools -- such as pre-clinical models, antibodies and cell lines -- and their use in laboratory experiments, as well as to devel...Read More
September 06, 2013
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host its first Clinical Trials Fair in Chicago on September 7, 2013, to raise awareness and understanding of local Parkinson's research opportunities among patients, their families and friends, and other interested volunteers.
"We as patients and loved ones have to do something. We are the ones looking for answers, and if we don't raise our hands and start participating in clinical trials, we'll never get to a cure," said Parkin...Read More
Access to Clinical Data and Biospecimens, and Funding to Use Them, from The Michael J. Fox Foundation Encourages Drug Development
July 17, 2013
NEW YORK, NY - The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced that qualified researchers may now request access to clinical data and biospecimens from a collection of studies exploring promising areas in Parkinson's research. The Foundation is also offering funding for use and analysis of the available information and materials to progress therapeutic and disease-modifying treatments.
"The standardized collection of data and samples that The Michael J. Fox Foundatio...Read More
Promising Parkinson's Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development
July 12, 2013
NEW YORK, NY - Research projects from five biopharmaceutical companies in the United States, Canada and Israel comprise the 2013 first half (1H 2013) of The Michael J. Fox Foundation for Parkinson's Research (MJFF) Partnering Program. Among the most promising in the MJFF portfolio, Partnering Program participants' research projects are presented directly to industry groups who may wish to invest in further development of the project. By connecting industry leaders with those studies ripe for inv...Read More
June 04, 2013
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has committed up to $10 million to its next funding round for the Edmond J. Safra Core Programs for PD Research to prioritize research toward transformative treatments and a cure for Parkinson's disease (PD).
The Edmond J. Safra Core Programs include the Rapid Response Innovation Awards, focused on breakthrough ideas, Target Validation, which supports testing of biological targets with potential to become the new PD drugs of the futu...Read More
Alim Louis Benabid, MD, PhD, Awarded 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research by The Michael J. Fox Foundation
May 31, 2013
May 08, 2013
NEW YORK, NY-The Michael J. Fox Foundation (MJFF) is today announcing the launch of three new funding programs focused on driving research toward transformative treatments and a cure for Parkinson's disease (PD). Two programs will promote critical work on the promising therapeutic targets LRRK2 and Parkin. A third program allows researchers to propose developing biomarkers of cognitive impairment in PD. The new funding opportunities are open to both academic and industry researchers.
In additio...Read More
"Machine Learning Approach" to Smartphone Data Garners $10,000 First Prize in The Michael J. Fox Foundation Parkinson's Data Challenge
April 24, 2013
The contest received an enthusiastic response from the scientific community -- the winning entry was chosen following more than 630 downloads of the dataset from teams in 21 countries.
The LIONsolver team's winning entry provided proof of concept for a "machine...Read More
The Michael J. Fox Foundation Launches New Arm of Parkinson's Progression Markers Initiative Studying At-Risk Populations in Parkinson's Disease
April 23, 2013
Sixteen International Parkinson's Disease Organizations Join Forces to Raise Global Awareness for Clinical Trial Participation
April 11, 2013
Sixteen Parkinson's disease (PD) organizations from around the world have come together as Clinical Trial Recruitment Community Partners to urge people living with Parkinson's, care partners and others to participate in clinical trials. The goal of this innovative engagement effort within the Parkinson's community is to raise awareness about the need for trial participants, educate about what it means to participate in research and provide actionable steps that anyone can take to get involved in...Read More
The Michael J. Fox Foundation for Parkinson's Research Supports the Obama Administration's Brain Activity Map Initiative
April 02, 2013
Today, President Obama announced the Brain Activity Map Initiative, starting with an investment of $100 million in 2014. This broad effort to advance knowledge of the human brain could not only lead to new understanding of the unfathomably complex workings of the normal human brain, but also help to unlock new approaches to treating brain disease. On behalf of The Michael J. Fox Foundation for Parkinson's Research, CEO Todd Sherer, PhD, issued this statement:
Since its founding in 2000, The Mi...Read More
March 19, 2013
New York, NY and Geneva, Switzerland - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, and The Michael J. Fox Foundation for Parkinson's Research announced today that the Foundation awarded a $1,000,000 grant to Addex to help fund continued human clinical testing of dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). One-third of people with PD develop dyskinesia within four to six ye...Read More
February 27, 2013
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that with the help of the Parkinson's community, it has completed and surpassed the $50-million Brin Wojcicki Challenge. Longtime Foundation supporters Sergey Brin and Anne Wojcicki have matched more than $53 million in capacity-building gifts received by MJFF from January 1, 2011, to December 31, 2012.
Mr. Brin and Ms. Wojcicki, the Foundation's largest donors for several years running, spearheaded the Challenge to spur do...Read More
February 20, 2013
NEW YORK, NY - The Michael J. Fox Foundation (MJFF) is today announcing the launch of four new funding programs focused on driving forward research toward transformative treatments and a cure for Parkinson's disease (PD). MJFF places a strong emphasis on translational and clinical research, but also supports high-risk/high-reward discovery work to help keep new ideas flowing into the drug development pipeline.
The new funding opportunities are open to both academic and industry researchers. Pro...Read More
February 06, 2013
NEW YORK, NY - The Michael J. Fox Foundation (MJFF) is launching a $10,000 research challenge to spur ideas for using patient data, collected using smartphones, in Parkinson's disease (PD) monitoring and treatment.
"Our Foundation is committed to developing opportunities for patients to contribute data about the real experience of Parkinson's disease, which researchers can leverage in pursuit of a cure," said Maurizio Facheris, MD, MSc, associate director of research programs at MJFF. "Many sym...Read More
Mrs. Lily Safra and The Edmond J. Safra Foundation Make New Gifts Totaling $6.5 Million to The Michael J. Fox Foundation
January 18, 2013
NEW YORK, NY - The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced new gifts totaling $6.5 million from Mrs. Lily Safra and The Edmond J. Safra Foundation. A pledge of $4.5 million over two years from the Edmond J. Safra Foundation, and a personal gift of $2 million from Mrs. Lily Safra, are the latest expressions of a continuing partnership to speed medical breakthroughs and a cure for Parkinson's disease. Together with Mrs. Safra's personal gift of $1 million from her Jewel...Read More